Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
European Journal of Human Genetics : EJHG
|
February 26, 2025
Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants
David E Goldsbury, Yoon-Jung Kang, Catherine Tang, et al.
American Journal of Epidemiology
|
May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium
Nicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Eun Young Kang, Dane Cheasley, Cecile LePage, et al.
Gynecologic Oncology
|
November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinoma
Nicola S Meagher, Phineas Hamilton, Katy Milne, et al.
British Journal of Cancer
|
June 29, 2026
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium
Nicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Gynecologic Oncology
|
June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Zhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
The Journal of Clinical Investigation
|
October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Brad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
The Journal of Pathology
|
December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Nicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
British Journal of Cancer
|
April 19, 2023
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
Denise G O'Mahony, Susan J Ramus, Melissa C Southey, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
European Journal of Human Genetics : EJHG
|
February 26, 2025
Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants
David E Goldsbury, Yoon-Jung Kang, Catherine Tang, et al.
American Journal of Epidemiology
|
May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium
Nicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Eun Young Kang, Dane Cheasley, Cecile LePage, et al.
Gynecologic Oncology
|
November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinoma
Nicola S Meagher, Phineas Hamilton, Katy Milne, et al.
British Journal of Cancer
|
June 29, 2026
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium
Nicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Gynecologic Oncology
|
June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Zhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
The Journal of Clinical Investigation
|
October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Brad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
The Journal of Pathology
|
December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Nicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
British Journal of Cancer
|
April 19, 2023
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
Denise G O'Mahony, Susan J Ramus, Melissa C Southey, et al.
Page
of 9